Abstract
For over two decades, calcium phosphates have been the focus of many laboratory and clinical investigations (1–8). Particular interest has surrounded calcium hydroxyapatite (HA), a naturally occurring calcium phosphate present in tooth enamel and vertebrate bone. In the early 1980’s, the dental community began using HA blocks and coatings to augment bone and encourage fixation in restorative dental procedures ; the chemical stability and excellent biocompatibility of HA made it an attractive material choice (1, 5, 9, 10). Subsequently, the orthopaedic community investigated and began using HA for bone defect obliteration and as an implant coating, with encouraging results (3, 11, 12). More recently, attention has been given to biphasic calcium phosphates (BCP), which combine HA and tricalcium phosphate (TCP) in different ratios. Solid, porous, and granular forms of HA and BCP materials have been employed for filling defects (13–16). Current studies involving the use of block HA as a drug delivery system and the use of HA with either bone cement or growth factors all show promise, as do HA composite materials, such as BCP (17–19).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference list
Lacefield WR (1998) Current status of ceramic coatings for dental implants. Implant Dent. 7(4):315–22.
Spivak JM, Hasharoni A (2001) Use of hydryoxyapatite in spine surgery. Eur. Spine J. 10:Suppl 2: S197–S204.
Bucholz RW (2002) Nonallograft osteoconductive bone graft substitutes. Clin. Orthop. 395:44–52.
Geesink RGT (2002) Osteoconductive coatings for total joint arthroplasty. Clin. Orthop. 395:53–65.
Block MS, Kent JN (1984) Long term radiographic evaluation of HA-augmented mandibular alveolar ridges. J. Oral. Maxillofac. Surg. 42.
Driskell TD, Hassler CR, McCoy LR (1973) The significance of resorbable bioceramics in the repair of bone defects. Proceedings of the 26th Annual Conference on Medical Biomaterials. Vol. 15. p. 199.
Epinette JA, Geesink RGT (1995), eds. Hydroxyapatite Coated Hip and Knee Arthroplasty. Vol. 51. Cahiers d’enseignement de la SOFCOT.
Epinette JA (1995) HA-coated hip implants: a 10 year follow-up. Eur. J. Orthop. Surg. Traumatol. 9: 83–5.
Jarcho M (1992) Retrospective analysis of hydroxyapatite development for oral implant applications. Dent. Clin. North. Am. 36:19–26.
Kent JN, Quinn JH, Zide MF, Guerra LR, Boyne PJ (1983) Alveolar ridge augmentation using nonresorbable HA with or without autogenous cancellous bone. J. Oral. Maxillofac. Surg. 41:629–42.
Larsson S, Bauer TW (2002) Use of injectable calcium phosphate cement for fracture fixation: a review. Clin. Orthop. 395:23–32.
Koshino T, Murase T, Takagi T, Saito T (2001) New bone formation around porous hydroxyapatite wedge implanted in opening wedge high tibial osteotomy in patient with osteoarthritis. Biomaterials. 22:1579–82.
Ayers RA, Simske S.1, Nunes CR, Wolford LM (1998) Long-term bone ingrowth and residual microhardness of porous block hydroxyapatite implants in humans. J. Oral. Maxillofac. Surg. 56:1297–301.
Oonishi H, Iwaki Y, Kin N, Kushitani S, Murata N, Wakitani S, Imoto K (1997) Hydroxyapatite in revision of total hip replacements with massive acetabular defects. J. Bone Joint Surg. Br. 79:87–92.
Hinz P, Wolf E, Schwesinger G, Hartelt E, Ekkernkamp A (2002) A new resorbable bone void filler in trauma: early clinical experience and histologic evaluation. Orthopedics. 25:5597–S600.
Adenis JP, Bertin P, Lasudry JG, Boncoeur-Martel MP, Leboutet MJ, Robert PY (1999) Treatment of postnucleation socket syndrome with a new hydroxyapatite tricalcium phosphate ceramic implant. Ophthal. Plast. Reconstr. Surg. 15:277–83.
Alam I, Asahina I, Ohmamiuda K, Enomoto S (2001) Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. J. Biomed. Mater. Res. 54:129–38.
Rogers-Foy JM, Powers DL, Brosnan DA, Barefoot SF, Friedman RJ, La Berge M (1999) Hydroxyapatite composites designed for antibiotic drug delivery and bone reconstruction: a caprine model. J. Invest. Surg. 12:263–75.
Itokazu M, Matsunaga T, Kumazawa S, Yang WA (1995) Novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation. J. Appl. Biomater. 6:167–9.
Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN (2001) Bone-graft substitutes: facts, fictions, and applications. J. Bone Joint Surg. 83A(Suppl 2, Part 2):S98–S 103.
Urist MR (1980) Bone transplants and implants, In: Fundamental and Clinical Bone Physiology, Urist, M.R., Editor. J.B. Lippincott: Philadelphia. p. 331–68.
Damien CJ, Parsons JR (1991) Bone graft and bone graft substitutes: a review of current technology and applications. J. Appl. Biomater. 2:187–208.
Einhorn TA (1995) Enhancement of fracture-healing. J. Bone Joint Surg. 77-A(6):940–56.
Bolander ME (1992) Regulation of fracture repair by growth factors. Proc. Soc. Exper. Biol. and Med. 200:165–70.
Black J (1988) Ceramics and composites, In: Orthopaedic Biomaterials in Research and Practice. Churchill Livingstone, Inc: New York, NY. p. 191–211.
Jarcho M (1981) Calcium phosphate ceramics as hard tissue prosthetics. Clin. Orthop. 157:259–78.
Chang YL, Lew D, Park JB, Keller JC (1999) Bio-mechanical and morphometric analysis of hydroxyapatite-coated implants with varying crystallinity. J. Oral Maxillofac. Surg. 57:1096–108.
Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Lindholm TC (1995) Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass and tricalcium phosphate implanted in sheep diaphyseal defects. Biomaterials. 16:1175–9.
Malard O, Bouler JM, Guicheux J, Heymann D, Pilet P, Coquard C, Daculsi G (1999) Influence of biphasic calcium phosphate granulometry on bone ingrowth, ceramic resorption, and inflammatory reactions: preliminary in vitro and in vivo study. J. Biomed. Mater. Res. 46:103–11.
Harada Y, Wang JT, Doppalapudi VA, Willis AA, Jasty M, Harris WH, Nagase M, Goldring SR (1996) Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro. J. Biomed. Mater. Res. 31:19–26.
Klein CPAT, Driessen AA, de Groot K (1984) Relationship between the degradation behavior of calcium phosphate ceramics and their physical-chemical characteristics and ultrastructrual geometry. Biomaterials. 5:157–60.
Hoogendorn HA, Renooij W, Akkermans LMA, Visser W, Wittebol P (1984) Long term study of large ceramic implants (porous hydroxyapatite) in dog femora. Clin. Orthop. 187:281–8.
Lee DR, Lemmons JE, LeGeros RZ (1989) Dissolution characteristics of commercially available HA particulate. 15th Annual Meeting of the Society for Biomaterials. Vol. 161. Lake Buena Vista, FL.
Clerics L, Fernandez-Pradas JM, Sardin G, Morenza JL (1998) Dissolution behaviour of calcium phosphate coatings obtained by laser ablation. Biomaterials. 19:1483–87.
Daculsi G (1998) Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials. 19:1473–78.
Klein CP, de Blieck-Hogervorst JM, Wolke JG, de Groot K (1990) Studies of the solubility of different calcium phosphate ceramic particles in vitro. Biomaterials. 11:509–12.
Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J. Periodontol. 63:729–35.
Toth JM, An HS, Lim TH, Ran Y, Weiss NG, Lundberg WR, Xu RM, Lynch KL (1995) Evaluation of porous biphasic calcium phosphate ceramics for anterior cervical interbody fusion. Spine. 20:2203–10.
Klein CPAT, Driessen AA, de Groot K, van den Hooff A (1983) Biodegradation behavior of various calcium phosphate materials in bone tissue. J. Biomed. Mater. Res. 17:769–84.
Bauer TW, Geesink RGT, Zimmerman R, McMahon JT (1991) Hydroxyapatite-coated femoral stems. Histological analysis of components retrieved at autopsy. J. Bone Joint Surg. Am. 73:1439–52.
Overgaard S, Lind M, Glerup H, Bunger C, Stballe K (1998) Porous-coated versus grit-blasted surface texture of hydroxyapatite-coated implants during controlled mircomotion: mechanical and histomorphometric results. J. Arthroplasty. 13:449–58.
Okumura M, Ohgushi H, Dohi Y, Katuda T, Tamai S, Koerten HK, Tabata S (1997) Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J. Biomed. Mater Res. 37:122–29.
Holmes RE, Hagler HK. Porous HA (1987) as a bone graft substitute in mandibular contour augmentation: a histometric study. J. Oral Maxillofac. Surg. 45:421–29.
Holmes RE, Hagler HK (1988) Porous hydroxyapatite as a bone graft substitute in maxillary augmentation. A histometric study. J. Craniofac. Surg. 16:199–205.
Chang BS, Lee CK, Hong KS, Youn HJ, Ryu HS, Chung SS, Park KW (2000) Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials. 21:1291–8.
Okazaki A, Koshino T, Saito T, Takagi T (2000) Osseous tissue reaction around hydroxyapatite block implanted into proximal metaphysic of tibia of rat with collagen-induced arthritis. Biomaterials. 21:483–7.
Steffen T, Stoll T, Arvinate T, Schenk RK (2001) Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery. Eur. Spine J. 10(Suppl 2): S132–S140.
Guo L, Guo X, Leng Y, Cheng JC, Zhang X ( 2001). Nanoindentation study of interfaces between calcium phosphate and bone in an animal spinal fusion model. J. Biomed. Mater. Res. 54:554–9.
Itokazu M, Kumazawa S, Wada E, Yang W (1996) Sustained release of adriamycin from implanted hydroxyapatite blocks for the treatment of experimental osteognic sarcoma in mice. Cancer Lett. 107:11–8.
Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K (1992) Calcium hydroxyapatite ceramics used as a delivery system for antibiotics. J. Bone Joint Surg. Br. 74:600–4.
Wippermann B, Donow C, Schratt HE, den Boer FC, Blokhuis T, Patka P (1999) The influence of hydroxyapatite granules on the healing of a segmental defect filled with autologous bone marrow. Ann. Chir. Gyn. 88:194–7.
Grundel RE, Chapman MW, Yee T, Moore DC (1991) Autogeneic bone marrow and porous biphasic calcium phospahte ceramic for segmental bone defects in the canine ulna. Clin. Orthop. 266:244–58.
Stelnicki EJ, Ousterhout DK (1997) Hydroxyapatite paste (Bone Source) used as an onlay implant for supraorbital and malar augmentation. J. Craniofac. Surg. 8:367–72.
Petruzzelli GJ, Stankiewicz JA (2002) Frontal sinus obliteration with hydroxyapatite cement. Laryngoscope. 112:32–6.
Joosten U, Joist A, Frebel T, Walter M, Langer M (2000) The use of an in situ curing hydroxyapatite cement as an alternative to bone graft following removal of enchondroma of the hand. J. Hand. Surg. Br. 25:288–91.
Kwon SY, Kim YS, Woo YK, Kim SS, Park JB (1997) Hydroxyapatite impregnated bone cement: in vitro and in vivo studies. Biomed. Mater. Eng. 7:129–40.
Dalby MJ, Di Silvio L, Harper EJ, Bonfield W (2001) Initial interaction of osteoblasts with the surface of a hydroxyapatite-poly(methylmethacrylate) cement. Biomaterials. 22:1739–47.
Morita S, Furuya K, Kazuhiko I, Nakabayashi N (1998) Performance of adhesive bone cement containing hydroxyapatite particles. Biomaterials. 19:1601–6.
Oonishi H, Kadoya Y, Iwaki H, Kin N (2000) Hydroxyapatite granules interposed at bone-cement interface in total hip replacements: histological study of retrieved specimens. J. Biomed. Mater. Res. 53:17480.
Ohura K, Bohner M, Hardouin P, Lemaitre J, Pasquier G, Flautre B (1996) Resorption of, and bone formation from, new beta-tricalcium phosphate-monocalcium phosphate cements: an in vivo study. J. Biomed Mater Res. 30:193–200.
Manley MT (1993) Calcium phosphate biomaterials: a review of the literature, In: Hydroxyapatite Coatings in Orthopaedic Surgery, Geesink, R.G.T. and Manley, M.T., Editors. Raven Press: New York. p. 1–24.
Geesink R, DeGroot K, Klein C (1988) Bonding of bone to apatite-coated implants. J. Bone Joint Surg. Br. 70:17–22.
Cook SD, Thomas KA, Kay JF, Jarcho M (1988) Hydroxyapatite-coated titanium for orthopedic implant applications. Clin. Orthop. 232:225–43.
DeGroot K, Geesink RGT, Klein CPAT, Serekian P (1987) Plasma sprayed coatings of HA. J. Biomed. Mater. Res. 21:1375–81.
DeGroot K (1983) Bioceramics of Calcium Phosphates, Boca Raton, FL: CRC Press, Inc.
Block MS, Kent JN, Kay JF (1987) HA-coated titanium dental implants in dogs. J. Oral. Maxillofac. Surg. 42:793–807.
Hayashi K, Uenoyama K, Matsuguchi N, Sugioka Y (1991) Quantitative analysis of in vivo tissue responses to titanium-oxide and hydroxyapatite-coated titanium alloy. J. Biomed. Mater. Res. 25: 515–23.
Boone PS, Zimmerman MC, Gutteling E, Lee CK, Parsons JR, Langrana N (1989) Bone attachment to hydroxyapatite-coated polymers. J. Biomed. Mater. Res. 23(A2):183–99.
Manley MT, Kay JF, Yoshiya S, Stern LS (1987), Stulberg BN: Accelerated fixation of weight bearing implants by HA coatings. Orthopedic Research Society 33rd Annual Meeting. Vol. 12. p. 214, San Francisco, California.
Manley MT, Kay JF, Uratsuji M, Stern LS, Stulberg BN (1987) Fixation of porous titanium and smooth HA interfaces in a loaded model. 13th Annual Meeting of the Society of Biomaterials. p. 210, New York, NY.
Manley MT, Gaisser DM, Uratsuji M, Stulberg BN, Bauer TW, Stern LS (1988) Fixation of porous titanium and smooth HA interfaces in a loaded model. 34th Annual Meeting, Orthopaedic Research Society. p. 332, Atlanta, GA.
Pazzaglia UE, Brossa F, Zatti G, Chiesa R, Andrini L (1998) The relevance of hydroxyapatite and spongious titanium coatings in fixation of cementless stems. An experimental comparative study in rat femur employing histological and microangiographic techniques. Arch. Orthop. Trauma. Surg. 117:279–85.
Marinoni EC, Fontana A, Castellano S (1995) Osteointegration of 96 cementless hip prostheses with hydroxyapatite coating: 5 years follow-up. Chir. Organi Mov. 80:147–55.
Soballe K (1993) Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop. Scand. Suppl. 255:1–58.
Thomas KA, Cook SD, Kay JF, Jarcho M, Anderson RC, Harding AF, Reynolds MC (1986) Attachment strength and histology of HA coated implants, In: Biomedical Engineering v. Recent Developments. Proceedings of the Fifth Southern Biomedical Engineering Conference, Saha, S., Editor. Pergamon Press: New York, NY. p. 205–11.
Rivero DP, Fox J, Skipor AK, Urban RM, Galante JO (1988) Calcium phosphate coated porous titanium implants for enhanced skeletal fixation. J. Biomed. Mater. Res. 22:191–201.
Cook SD, Thomas KA, Dalton JE, Volkman TK, Whitecloud III TS, Kay JF (1992) HA coating of porous implants improves bone ingrowth and interface attachment strength. J. Biomed. Mater. Res. 26:989–1001.
Cook SD, Thomas KA, Kay JF, Jarcho M (1988) Hydroxyapatite-coated porous titanium for use as an orthopedic biologic attachment system. Clin. Orthop. 230:303–12.
Ramires PA, Romito A, Cosentino F, Milella E (2001) The influence of titania/hydroxyapatite composite coatings on in vitro osteoblasts behaviour. Biomaterials. 22:1467–74.
Caropreso S, Cerroni L, Marini S, Cocchia D, Martinetti R, Condo SG (1997) Necessity and validity of standard models for experimental preclinical evaluation of biomaterials. An example of biologic characterization of a hydroxyapatite-based implant material. Minerva Stomatol. 46:45–50.
Ruano R, Jaeger RG, Jaeger MM (2000) Effect of a ceramic and a non-ceramic hydroxyapatite on cell growth and procollagen synthesis of cultured human gingival fibroblasts. J. Periodontol. 71:540–5.
Sun JS, Lin FH, Hung TY, Tsuang YH, Chang WH, Liu HC (1999) The influence of hydroxyapatite particles on osteoclast cell activities. J. Biomed. Mater. Res. 45:311–21.
Gumaer KI, Salsbury RL, Sauerschell RJ, Slighter RG, Drobeck HP (1985) Evaluation of hydroxylap-atite root implants in baboons. Journal of Oral and Maxillofacial Surgery. 44:73–9.
Daculsi G, LeGeros RZ, Nery E, Lynch K, Kerebel B (1989) Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. Biomed. Mater. Res. 23:883–94.
Drobeck HP, Rothstein SS, Gumaer KI, Sherer AD, Slighter RG (1984) Histologic observations of soft tissue responses to implanted, multifaceted particles and discs of HA. Journal of Oral and Maxillofacial Surgery. 42:143–9.
Eggli PS, Muller RW, Schenk RK (1988) Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphic and histologic study of bony ingrowth and implant substitution. Clin. Orthop. 232:127–38.
Bell R, Beirne OR (1988) Effect of HA, tricalcium phosphate, and collagen on the healing of defects in the rat mandible. Journal of Oral and Maxillofacial Surgery. 46:589–94.
Lin TC, Su CY, Chang CS (1997) Stereomorphologic observation of bone tissue response to hydroxyapatite using SEM with the EDTA-KOH method. J. Biomed. Mater. Res. 36:91–7.
Furukawa T, Matsusue Y, Yasunaga T, Shikinami Y, Okuno M, Nakamura T (2000) Biodegradation behavior of ultra-high-strength hydroxyapatite/poly (L-lactide) composite rods for internal fixation of bone fractures. Biomaterials. 21:889–98.
Yoshimine Y, Akamine A, Mukai M, Maeda K, Matsukura M, Kimura Y, Makishima T (1993) Biocompatibility of tetracalcium phosphate cement when used as a bone substitute. Biomaterials. 14:403–6.
Liu C, Wang W, Shen W, Chen T, Hu L, Chen Z (1997) Evaluation of the biocompatibility of a nonceramic hydroxyapatite. J. Endod. 23:490–3.
Wu H, Zhu TB, Du JY, Hong GX, Sun SZ, Xu XH (1992) Analysis of the biocompatibility of magnetic porous tricalcium phosphate ceramics in rat femurs. .1. Tongji Med. Univ. 12:111–5.
Dieppe PA, Huskisson EC, Crocker P, Willoughby DA (1976) Apatite deposition disease. A New Arthropathy. Lancet. 1(7954):266–9.
Nagase M, Baker DG, Schumacher HR (1988) Prolonged inflammatory reactions induced by artificial ceramics in the rat air pouch model. J. Rheumatol. 15:1334–8.
Rooney T, Berman S, Indresano AT (1988) Evaluation of porous block HA for augmentation of aveolar ridges. J. Oral. Maxillofac. Surg. 46:15–8.
dos Santos LA, Carrodeguas RG, Rogero SO, Higa OZ, Boschi AO, De Arruda AC (2002) Alpha-tricalcium phosphate cement: in vitro cytotoxcity. Biomaterials. 23:2035–42.
Anderson GI, Orlando K, Waddell JP (2001) Synovitis subsequent to total-hip arthroplasty with and without hydroxyapatite coatings: a study in dogs. Vet. Surg. 30:311–8.
Mommaerts MY, Nadjmi N, Abeloos JV, Neyt LF (1999) Six years experience with zygomatic “sandwich” osteotomy for correction of malar deficiency. J. Oral. Maxillofac. Surg. 57:8–13.
Cormack DH (1987) Ham’s Histology, ed. 9, Philadelphia, PA: J.B. Lippincott Co. pp. 283–87.
Johnson KD, Frierson KE, Keller TS, Cook C, Scheinberg R, Zerwekh J, Meyers L, Sciadini MF (1996) Porous ceramics as bone graft substitutes in long bone defects: a biomechanical, histological, and radiographic analysis. J. Orthop. Res. 14:351–69.
Zerwekh JE, Kourosh S, Scheinberg R, Kitano T, Edwards ML, Shin D, Selby DK (1992) Fibrillar collagen-biphasic calcium phosphate composite as a bone graft substitute for spinal fusion. J. Orthop. Res. 10:562–72.
Chapman MW, Bucholz R, Cornell C (1997) Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J. Bone Joint Surg. (Am). 79:495–502.
Muschler GF, Negami S, Hyodo A, Gaisser D, Easley K, Kambic H (1996) Evaluation of collagen ceramic composite graft materials in a spinal fusion model. Clin. Orthop. 328:250–60.
Bell R, Beirne OR (1988) Effect of HA, tricalcium phosphate, and collagen on the healing of defects in the rat mandible. J. Oral. Maxillofac. Surg. 46:589–94.
Takaoka T, Okumura M, Ohgushi H, Inoue K, Takakura Y, Tamai S (1996) Histological and biochemical evaluation of osteogenic response in porous hydroyapatite coated alumina ceramics. Biomaterials. 17:1499–505.
Yoshikawa T, Ohgushi H, Tamai S (1996) Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J. Biomed. Mater. Res. 32:481–92.
Frame JW (1987) Hydroxyapatite as a biomaterial for alveolar ridge augmentation. Int. J. Oral. Maxillofac. Surg. 16:642–55.
Munting E (1996) The contributions and limitations of hydroxyapatite coatings to implant fixation: A histomorphometric study of load bearing implants in dogs. Int. Orthop. 20:1–6.
Levine JP, Bradley J, Turk AE, Ricci JL, Benedict JJ, Steiner G, Longaker MT, McCarthy JG (1997) Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit. Ann. Plast. Surg. 39(2):158–68.
Reddie AH (2001) Bone morphogenetic proteins: from basic science to clinical applications. J. Bone Joint Surg. 83A(Suppl 1, Part 1):S1–S6.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science. 242:1528–34.
Koempel JA, Patt BS, O’Grady K, Wozney J, Toriumi DM (1998) The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone. J. Biomed. Mater. Res. 5:359–63.
Noshi T, Yoshikawa T, Dohi Y, Ikeuchi M, Horiuchi K, Ichijima K, Sugimura M, Yonemasu K (2001) Recombinant human bone mophogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs. 25:201–8.
Noshi T, Yoshikawa T, Ikeuchi M, Dohi Y, Ohgushi H, Horiuchi K, Sugimura M, Ichijima K, Yonemasu K (2000) Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J. Biomed. Mater. Res. 52:621–30.
Ripamonti U, Ramoshebi LN, Matsaba T, Tasker J, Crooks J, Teare J (2001) Bone induction by BMPs/OPs and related family members in primates. .1. Bone Joint. Surg. 83-A(Suppl 1):S116–27.
Lind M, Overgaard S, Jensen TB, Song Y, Goodman SB, Bunger C, Soballe K (2001) Effect of osteogenic protein 1/collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate. J. Biomed. Mater. Res. 55:89–95.
Oda S, Kinoshita A, Higuchi T, Shizuya T, Ishikawa I (1997) Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Med. Dent. Sci. 44:53–62.
Cranin AN, Satler NM (1984) Human mandibular alveolar ridge augmentation with HA: final report of a five year investigation. 10th Annual Meeting of the Society for Biomaterials. p. 324, Washington, DC.
Holmes RE, Wardrop RW, Wolford LM (1988) HA as a bone graft substitute in orthognathic surgery: histologic and histometeric findings. J. Oral. Maxillofac. Surg. 46:661–71.
Kent JN, Quinn JH, Zide MF, Finger IM, Jarcho M, Rothstein SS (1982) Correction of alveolar ridge deficiencies with nonresorbable HA. J. Am. Dent. Assoc. 105:993–1001.
Rothstein SS, Paris D, Sage B (1984) Use of durapatite for the rehabilitation of resorbed alveolar ridges. J. Am. Dent. Assoc. 109:571–74.
Meadows G (2002) Adjunctive use of ultraporous beta-tricalcium phosphate bone void filler in spinal arthrodesis. Orthopedics. 25(5 Suppl):S579–84.
Szabo G, Suba Z, Hrabak K, Barabas J, Nemeth Z (2001) Autogenous bone versus beta-tricalcium phosphate graft alone for bilateral sinus elevations (2- and 3-dimensional computed tomographic, histologic, and histomorphometric evaluations): preliminary results. Int. J. Oral. Maxillofac. Implants. 16:681–92.
Muschik M, Ludwig R, Halhubner S, Brursche K, Stoll T (2001) Beta-tricalcium phosphate as a bone substitute for dorsal spinal fusion in adolescent idiopathic scoliosis: preliminary results of a prospective clinical study. Eur. Spine J. 10(Suppl 2):S178–184.
Russotti GM, Okada Y, Fitzgerald RH, Chao EYS, Gorski JP (1987) Efficacy of using a bone graft substitute to enhance biological fixation of a porous metal femoral component, In: The Hip: proceedings of the 15th open scientific meeting of the Hip Society. p. 120–54.
Vedantam R, Ruddlesdin C (1996) The fully hydroxyapatite-coated total hip implant. J. Arthroplasty. 11:534–42.
D’Antonio JA, Capello WN, Manley M (1996) Remodeling of bone around hydroxyapatite-coated femoral stems. J. Bone Joint Surg. Am. 78:1226–34.
D’Antonio JA, Capello WN, Jaffe WL (1992) HA-coated implants: multi-center three-year clinical and radiographic results. Clin. Orthop. 285:102–15.
D’Antonio JA, Capello WN, Manley MT, Geesink RGT (2001) Hydroxylapatite femoral stems for total hip arthroplasty: 10–13 year follow-up. Clin. Orthop. 393:101–11.
Hardy DCR, Frayssinet P, Guilhem A, LaFontaine MA, DeLince PE (1991) Bonding of hydroxyapatitecoated prostheses. Histopathology of specimens from four cases. J. Bone Joint Surg. Br. 73:732–40.
Bloebaum RD, Merrell M, Gustke K, Simmons M (1991) Retrieval analysis of a hydroxyapatite-coated hip prosthesis. Clin Orthop. 267:97–102.
Bauer TW (1993) The histology of HA-coated implants, In: HA Coatings in Orthopaedic Surgery, Geesink, R. and Manley, M., Editors. Raven Press: New York. p. 305–18.
Tonino AJ, Therin M, Doyle C (1999) HA-coated femoral stems. Histology and histomorphometry around five components retrieved at post mortem. J. Bone Joint Surg. Br. 81:148–54..
Thanner J, Karrholm J, Herberts P, Malchau H (1999) Porous cups with and without hydroxylapatite-tricalcium phosphate coating: 23 matched pairs evaluated with radiostereometry. J. Arthroplasty. 14:266–71.
Epinette JA, Manley MT, D’Antonio JA, Edidin AA, Capello WN (2003) A 10-Year Minimum Follow-Up of Hydroxyapatite-Coated Threaded Cups: Clinical radiographic and survivorship analyses with comparison to the literature. J. Arthroplasty. 18(2): 140–8.
Rights and permissions
Copyright information
© 2004 Springer-Verlag France
About this chapter
Cite this chapter
Manley, M.T., Sutton, K., Dumbleton, J. (2004). Calcium Phosphates: A Survey of the Orthopaedic Literature. In: Fifteen Years of Clinical Experience with Hydroxyapatite Coatings in Joint Arthroplasty. Springer, Paris. https://doi.org/10.1007/978-2-8178-0851-2_2
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0851-2_2
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-00508-4
Online ISBN: 978-2-8178-0851-2
eBook Packages: Springer Book Archive